Skip to main content
US EQUITIES PRE-MARKET CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
CN

CNTBStock

Nasdaq Global Market · Healthcare · US

$0.6652 last close 2026-11-18
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment CNTB's does — no target price to set, unlike a price alert.

Stable Ratio screen, 0 of 4 decided standards passing. No standard's deciding ratio sits within 3 points of its line. What would change it

Sharia status
NOT COMPLIANT
Per our in-house ratio engine
0 of 4 pass our own screen — 3 of 7 could not be computed
Purification 100.00% *
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure2 of 5 timeframes bullish · 87.0% aligned
VWAPPrice holding above VWAP ($0.62)
VolumeRelative volume 3.6× the 20-day average
Momentum10-day rate of change -14.8%

CNTB is currently considered not halal (non-compliant), per our in-house ratio engine. See the full ratio breakdown and business-activity screen below for the reasoning.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

434 other Healthcare stocks pass this same screen. See compliant Healthcare stocks →

Market & analysts
Wall Street consensus
BUY
13 analysts
Price target
$5.71
+759.0% · 7 analysts
Institutional own.
51.8%
of shares
Momentum (10d)
-14.8%
rate of change
SMC grade
B · 70
87.0% aligned
100.00% *
Purification ratio (secondary provider, uncertain)
B · 70
SMC grade — 87.0% timeframe alignment
-14.8%
Rate of change (10d)
BUY
Wall Street consensus (13)
$5.71
Price target (+759.0%) · 7 analysts
51.8%
Institutional ownership

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $42.9M as of 2026-11-19.

Business activity: cleared (no excluded categories detected)

AAOIFI Fail 1 of 2 ratios pass
RatioValueThresholdResult
Interest-bearing debt 1.16% 30.00% Pass(28.8pp buffer)
Interest-bearing investments 45.44% 30.00% Fail(15.4pp over)
Usmani Fail 2 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 1.79% 33.00% Pass(31.2pp buffer)
Interest-bearing investments 70.19% 33.00% Fail(37.2pp over)
Non-liquid assets 26.97% at least 20.00% Pass(7.0pp above the floor)
MSCI Fail 1 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 1.79% 33.33% Pass(31.5pp buffer)
Cash + interest-bearing securities 70.19% 33.33% Fail(36.9pp over)
Accounts receivable 73.03% 33.33% Fail(39.7pp over)
FTSE Fail 1 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 0.00% 33.33% Pass(33.3pp buffer)
Cash + interest-bearing securities 70.19% 33.33% Fail(36.9pp over)
Accounts receivable 73.03% 50.00% Fail(23.0pp over)
Dow Jones Islamic Market Unverified⚠️ a figure this standard divides by was not available, so it could not be scored — the rows below show what was and was not computed 3 of 3 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 0.45% 33.00% Pass(32.5pp buffer)
Cash + interest-bearing securities 17.87% 33.00% Pass(15.1pp buffer)
Accounts receivable 0.72% 33.00% Pass(32.3pp buffer)
S&P Shariah Unverified⚠️ a figure this standard divides by was not available, so it could not be scored — the rows below show what was and was not computed 3 of 3 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 0.49% 33.00% Pass(32.5pp buffer)
Cash + interest-bearing securities 19.40% 49.00% Pass(29.6pp buffer)
Accounts receivable 0.78% 49.00% Pass(48.2pp buffer)
MSCI M-Series Unverified⚠️ a figure this standard divides by was not available, so it could not be scored — the rows below show what was and was not computed 3 of 3 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 0.49% 33.33% Pass(32.8pp buffer)
Cash + interest-bearing securities 19.40% 33.33% Pass(13.9pp buffer)
Accounts receivable 20.18% 49.00% Pass(28.8pp buffer)

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

Usmani (% of total assets)nonliquid assets ratio · floor 7.0pts
AAOIFI Standard 21 (% of market cap)debt ratio 28.8pts
Usmani (% of total assets)debt ratio 31.2pts
MSCI Islamic Index (% of total assets)receivables ratio 39.7pts
Usmani (% of total assets)investments ratio 37.2pts
MSCI Islamic Index (% of total assets)cash and interest ratio 36.9pts

The numbers the ratios are built from

Read from CNTB's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $64.0K 2026-09-30 RevenueFromContractWithCustomerExcludingAssessedTax
Interest-bearing debtShort and long-term borrowings $0 2026-09-30 no debt tag reported in 3+ years (treated as $0)
Cash and interest-bearing securitiesCash, equivalents and marketable securities $19.5M 2026-09-30 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents, ShortTermInvestments
Total assetsBalance sheet total $27.8M 2026-09-30 Assets
Market capDenominator for AAOIFI $42.9M live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $89.8M 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $98.5M 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $2.3M 2026-09-30 10-K text (no XBRL tag available)

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-11-16, period ended 2026-09-30. Income statement: Annual report (10-K) filed 2026-03-31, period ended 2026-09-30. Screened 2026-11-19.

  • Total assets$27.8M
    Assets · period ended 2026-09-30 · 10-Q filed 2026-11-16
  • Interest-bearing debt$0
    no debt tag reported in 3+ years (treated as $0) · balance sheet as of 2026-09-30 · no filing link for this figure
  • Cash and interest-bearing securities$19.5M
    CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $16.5M · period ended 2026-09-30 · 10-Q filed 2026-11-16
    ShortTermInvestments $3.0M · period ended 2026-09-30 · 10-Q filed 2026-11-16
  • Receivables$788.0K
    AccountsReceivableNetCurrent · period ended 2026-09-30 · 10-Q filed 2026-11-16
  • Revenue$64.0K
    RevenueFromContractWithCustomerExcludingAssessedTax · period ended 2025-12-31 · 10-K filed 2026-03-31
  • Interest income (non-permissible)$2.3M
    10-K text (no XBRL tag available) · income statement as of 2026-09-30 · no filing link for this figure
  • Market cap$42.9M
    Market quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-19 · not a filing figure, so no link

5 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.

What changed, and when

Verdict history for CNTB. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-11-19 Unverified → Fail filing re-screen

Tracked since 2026-09-07.

What would change the status

The headline verdict is the majority of the decided ratio standards — 0 pass and 4 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-19.

No standard's deciding ratio sits within 3 points of its line.

The ratios that move with the share price

AAOIFI's debt ratio (1.2% against a 30% line) would only fail if the market cap fell by 96%, to $1.7M.

AAOIFI's investments ratio is $19.5M cash and interest-bearing investments over a market cap of $42.9M (as of 2026-11-19), 45.4% against a 30% line.

It would pass if the market cap rose above $65.0M (+51%), about $1.01 a share against $0.67 implied by the screen's own figures.

AAOIFI would then be unverified, and the majority verdict would move from Not compliant to no verdict (0 of 3 decided standards passing).

At the screen's market cap, it would take $6.6M less cash and interest-bearing investments to clear the line.

AAOIFI would then be unverified, and the majority verdict would move from Not compliant to no verdict (0 of 3 decided standards passing, counting every standard that divides the same figure).

Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.

Shariah-compliant alternatives

Compliant companies in Biotechnology listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
VRTXVertex Pharmaceuticals, Inc. $121.1B —
REGNRegeneron Pharmaceuticals, Inc. $85.3B —
ARGXArgen X SE - ADR $64.3B —
ONCBeOne Medicines Ltd. American Depositary Shares $40.4B —
ALNYAlnylam Pharmaceuticals Inc $31.6B —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

Funds that hold CNTB

1 of the 224 funds whose filed holdings we currently hold own CNTB shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns CNTB.

Other funds
FundCNTB in fundFund compliant by weight
IWC iShares Micro-Cap ETF 0.01% 23%

Sorted by CNTB’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names CNTB once, so a bond is not counted as the shares; 1 more fund name CNTB in a way we cannot separate from its bonds, and is not listed. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.

3.692.912.131.360.582025-11-192026-05-212026-11-18

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
0.45
S2
0.50
S1
0.54
PIVOT
0.59
R1
0.63
R2
0.68
R3
0.72

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
0.4845 – 0.8459
±27.16% from 0.6652, made 2026-11-19 · resolves 2026-11-26
STRONG SELL
from 19 indicators
78.7% of our last 25417 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 53.4% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG SELL
19 indicators
OscillatorsNEUTRAL
2 buy · 3 neutral · 2 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)35.90NEUTRAL
Stochastic %K (14)35.38NEUTRAL
CCI (20)-125.63BUY
Williams %R (14)-64.62NEUTRAL
MACD (12,26,9)0.01BUY
ROC (10)-14.85SELL
Momentum (10)-0.12SELL
EMA (10)0.68SELL
SMA (10)0.68SELL
EMA (20)0.75SELL
SMA (20)0.74SELL
EMA (30)0.83SELL
SMA (30)0.79SELL
EMA (50)1.03SELL
SMA (50)0.96SELL
EMA (100)1.42SELL
SMA (100)1.61SELL
EMA (200)1.86SELL
SMA (200)2.08SELL

About CNTB

Healthcare · Biotechnology

Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.

connectbiopharm.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Grade verdict

Good setup, solid confluence

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 43
⏰ 4H BEARISH 40
🕐 1H BEARISH 98
⏱ 15-Min BULLISH 130
⏲ 5-Min BULLISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-14.8%
Rate of change (10d)
3.6×
Volume vs its 20-day average
-0.08
MACD (no fresh cross)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.